Highlights Inadequate sleep among adolescents has been increasing over the years with adverse health consequences. Non-pharmacological and pharmacological treatments are available for treating insomnia, with cognitive behavioral therapy recommended as the first line of treatment. Adolescence is a critical period to consider drug overdose risk post-prescription of benzodiazepine treatment. Benzodiazepines, approved by the USFDA for adults (≥18 years), are a class of medications prescribed for treating sleep disorders.
1 Given the lack of safety data for younger age groups, they are recommended less frequently among children. 2 The risk of drug overdose post-prescription of benzodiazepine treatment for insomnia is unclear, with no comparative evidence for the adolescent age group. 3 We have summarized a study entitled “Association of Benzodiazepine Treatment for Sleep Disorders with…
